Suggestions
Gordan Lauc
Professor of Biochemistry and Molecular Biology & Founder and CEO of Genos & CSO at GlycanAge
Professional Background
Gordan Lauc is a highly regarded scientist specializing in protein glycosylation, a critical posttranslational modification that significantly impacts protein structure and functionality. He currently serves as Chief Scientific Officer (CSO) of GlycanAge LTD, where he leads pioneering research efforts aimed at elucidating the intricate connections between glycan structures and human health. Under his leadership, GlycanAge is focused on analyzing the human glycome, a complex array of carbohydrates that play essential roles in various biological processes.
Before his tenure at GlycanAge, Gordan held numerous prestigious positions, including Director at the National Center of Excellence in Personalised Healthcare, where he advanced personalized medicine initiatives across multiple disciplines. His previous role as CEO at Genos Ltd has solidified his reputation as an authoritative figure in the glycomics field, influencing research, product development, and strategic direction in biochemistry and healthcare. Furthermore, Gordan has contributed a wealth of knowledge to academia through his roles as an Honorary Professor at King’s College London and as a professor at the Faculty of Pharmacy and Biochemistry at the University of Zagreb. His extensive experience also includes a visiting professorship at the renowned Johns Hopkins University in Baltimore, where he imparted his expertise to aspiring scientists and engaged in collaborative research projects.
Education and Achievements
Gordan began his academic journey at the Faculty of Science at the University of Zagreb, where he obtained both his Bachelor of Science degree in Molecular Biology and his Ph.D. in Biochemistry. These foundational studies provided him with the expertise necessary to explore the complexities of proteins and their glycan counterparts. His pursuit of knowledge further led him to The Johns Hopkins University, known for its leading-edge research and commitment to innovation in science and technology.
Throughout his illustrious career, Gordan has spearheaded large-scale studies that bridge the gap between the human glycome and genomic associations, aiming to uncover the functional significance of protein glycosylation in various health conditions and diseases. His research holds promise for advancements in personalized healthcare, enhancing our understanding of how individualized treatments can address complex biological challenges.
Achievements
Gordan’s contributions to the field of biochemistry and glycomics are manifold. He has published numerous research papers in peer-reviewed journals, advancing knowledge on how glycosylation affects protein interactions, immune responses, and cellular signaling pathways. His rigorous research methodologies and innovative approaches have earned him recognition not only in academic circles but also within industry networks.
Additionally, Gordan's leadership roles demonstrate his commitment to fostering interdisciplinary collaboration across science and healthcare domains. His vision for glycan research has led to collaborations with other academic institutions and industry partners, reinforcing the potential of glycomics in both therapeutic development and diagnostic advancements.
Gordan Lauc’s work continues to influence the landscape of biochemistry and healthcare, paving the way for new avenues in personalized medicine. His background, academic credentials, and extensive research experience firmly establish him as a leading figure in the field, dedicated to uncovering the critical roles that glycosylation plays in human health and disease.
